Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2007

01-06-2007 | Original Article

Glycodelin gene expression in human peripheral white blood cells

Authors: E. E. Lang, G. Venkatraman

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2007

Login to get access

Abstract

Background

Glycodelin plays an important role in normal and abnormal reproductive growth. The in vitro properties of glycodelin have been studied in K562 cells. The role of glycodelin in vivo in the peripheral circulation has not been determined.

Aim

To determine if circulating leukocytes in normal subjects express the glycodelin gene, with a view to understanding its contribution to various disease processes.

Method

RT-PCR analysis of mononuclear cells isolated from the blood of healthy volunteers was used to show glycodelin mRNA expression. Immunocytostaining was performed using anti-glycodelin antibody.

Results

PCR analysis illustrated the expression of the glycodelin gene in peripheral mononuclear cells. Glycodelin protein in these cells was confirmed with immunostaining.

Conclusion

The presence of glycodelin in peripheral white blood cells was demonstrated. The ability of glycodelin to stimulate angiogenesis and act as an immunosuppressive agent could be an indicator of the role of peripheral leukocytes in various disease states.
Literature
1.
go back to reference Bohn H, Kraus W, Winckler W (1982) New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta 4(Suppl):67–81PubMed Bohn H, Kraus W, Winckler W (1982) New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta 4(Suppl):67–81PubMed
2.
go back to reference Logdberg L, Wester L (2000) Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochem Biophys Acta 1482(1–2):284–297PubMed Logdberg L, Wester L (2000) Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochem Biophys Acta 1482(1–2):284–297PubMed
3.
go back to reference Yaniv E, Borovsky Z, Mishan-Eisenberg G, Rachmilewitz J (2003) Placental protein 14 regulates selective B cell responses. Cell Immunol 222:156–163PubMedCrossRef Yaniv E, Borovsky Z, Mishan-Eisenberg G, Rachmilewitz J (2003) Placental protein 14 regulates selective B cell responses. Cell Immunol 222:156–163PubMedCrossRef
4.
go back to reference Okamoto N, Uchida A, Takakura K et al (1991) Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol 26(4):137–142PubMed Okamoto N, Uchida A, Takakura K et al (1991) Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol 26(4):137–142PubMed
5.
go back to reference Oehninger S, Coddington CC, Hodgen GD, Seppala M (1995) Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril 63:377–383PubMed Oehninger S, Coddington CC, Hodgen GD, Seppala M (1995) Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril 63:377–383PubMed
6.
go back to reference Morrow DM, Xiong N, Getty RR et al (1994) Hematopoietic placental protein 14, an immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol 145:1485–1495PubMed Morrow DM, Xiong N, Getty RR et al (1994) Hematopoietic placental protein 14, an immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol 145:1485–1495PubMed
7.
go back to reference Bolton AE, Pockley AG, Clough KJ et al (1987) Identification of placental protein14 as an immunosuppressive factor in human reproduction. Lancet 1:593–595PubMedCrossRef Bolton AE, Pockley AG, Clough KJ et al (1987) Identification of placental protein14 as an immunosuppressive factor in human reproduction. Lancet 1:593–595PubMedCrossRef
8.
go back to reference Pockley AG, Barrett CL, Bolton AE (1989) Placental protein 14(PP14) content and immunosuppressive activity of human cervical mucus. Symp Soc Exp Biol 43:317–323PubMed Pockley AG, Barrett CL, Bolton AE (1989) Placental protein 14(PP14) content and immunosuppressive activity of human cervical mucus. Symp Soc Exp Biol 43:317–323PubMed
9.
go back to reference Song M, Ramaswamy S, Ramachandran S et al (2001) Angiogenic role for glycodelin in tumorigenesis. PNAS 98(16):9265–9270PubMedCrossRef Song M, Ramaswamy S, Ramachandran S et al (2001) Angiogenic role for glycodelin in tumorigenesis. PNAS 98(16):9265–9270PubMedCrossRef
10.
go back to reference Horowitz IR, Cho CH, Song MQ et al (2001) Plasma glycodelin levels in gynecological malignancies. Int J Gynecol Cancer 11:173–179PubMedCrossRef Horowitz IR, Cho CH, Song MQ et al (2001) Plasma glycodelin levels in gynecological malignancies. Int J Gynecol Cancer 11:173–179PubMedCrossRef
11.
go back to reference Podder AS, Kim JG, Gill KP et al (1998) Generation and characterization of a polyclonal antipeptide antibody to human glycodelin. Fertil Steril 69:543–548CrossRef Podder AS, Kim JG, Gill KP et al (1998) Generation and characterization of a polyclonal antipeptide antibody to human glycodelin. Fertil Steril 69:543–548CrossRef
12.
go back to reference Ramachandran S, Ramaswamy S, Cho CH, Parthasarathy S (1998) Lysophosphatidic acid induces glycodelin gene expression in cancer cells. Cancer Lett 177(2):197–202CrossRef Ramachandran S, Ramaswamy S, Cho CH, Parthasarathy S (1998) Lysophosphatidic acid induces glycodelin gene expression in cancer cells. Cancer Lett 177(2):197–202CrossRef
Metadata
Title
Glycodelin gene expression in human peripheral white blood cells
Authors
E. E. Lang
G. Venkatraman
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2007
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-007-0019-9

Other articles of this Issue 2/2007

Irish Journal of Medical Science (1971 -) 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.